News | 04 December 2012
The NASDAQ Biotechnology Index rose 10% in third quarter and is up 40.5% this year whereas S&P500 increase was only 12.1%. Although the $33 billion in biotech investment approached levels not seen since the venture boom 12 years ago in 2000, there ...
Click on the link to read the full article at Seeking Alpha
(This link will open in a new window)